Clinical Significance of Plasma Vasoactive Intestinal Polypeptides Level Detection in Cytomegalovirus Hepatitis

JIN Yu,HAO Li-hua,LI Mei,HE Zu-hui
2009-01-01
Abstract:Objective To observe the plasma vasoactive intestinal polypeptide(VIP) concentration in infants with cytomegalovirus(CMV) hepatitis and to explore the correlation between plasam VIP level and liver injury,cholestasis or biliary atresia. Methods Sixty-two infants with CMV hepatitis in Nanjing children′s hospital from Aug.2008 to May 2009 were divided into 4 groups,in which hepatits group contained 13 cases(male 8 cases,female 5 cases),cholestasis group contained 15 cases(male 8 cases,female 7 cases),hepatitis and cholestasis group contained 20 cases(male 11 cases,female 9 cases);and biliary atresia group contained 14 cases(male 7 cases,female 7 cases).Healthy control group contained 14 cases(male 8 cases,female 6 cases).Breast milk jaundice group contained 15 cases(male 7 cases,female 8 cases).The plasma VIP concentrations of infants with CMV hepatitis,and breast milk jaundice,healthy infants(healthy control group)were measured by using radioimmunoassay. Results VIP concentration in plasma of infants in hepatitis group [(61.75±8.30) ng/L] was higher than that in healthy control group [(41.83±9.30) ng/L P <0.05];VIP concentration in plasma of infants in cholestasis group [(63.73±3.54) ng/L] was obviously higher than that in healthy control group(P <0.01).And there was no significant difference between breast milk jaundice group and healthy control group [(35.16±10.14) ng/L P >0.05].The concentration of plasma VIP in hepatitis and cholestasis group[(53.62±4.00) ng/L] was significantly higher than that in healthy control group(P < 0.05);The plasma VIP concentration in biliary atresia group[(20.27±9.00) ng/L] was significantly less than that in healthy control group(P < 0.01). Conclusions Increased plasma VIP level is the result of liver injury and also the reason of promoting the formation of cholestasis in infants with CMV hepatitis.Increased plasma VIP level of infants with biliary atresia possibly reduces hepatobiliary injury by inhibiting hepatobiliary autoimmune responses,which shows the potential therapeutic value.
What problem does this paper attempt to address?